---
layout: post
title: A Preliminary Drug Classification Scheme/Ontology
date: '2010-11-09T08:00:00.001Z'
author: John Overington
tags: 
modified_time: '2010-11-09T15:37:50.502Z'
thumbnail: http://2.bp.blogspot.com/_SlPG9DIz_AA/TNlpph-EQpI/AAAAAAAAA6g/eFaaN2j5Vp4/s72-c/789562418_eaf97f9aff_o.jpg
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-5378977668177919662
---

<div class="separator" style="clear: both; text-align: center;"><a href="http://2.bp.blogspot.com/_SlPG9DIz_AA/TNlpph-EQpI/AAAAAAAAA6g/eFaaN2j5Vp4/s1600/789562418_eaf97f9aff_o.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="256" src="http://2.bp.blogspot.com/_SlPG9DIz_AA/TNlpph-EQpI/AAAAAAAAA6g/eFaaN2j5Vp4/s320/789562418_eaf97f9aff_o.jpg" width="320" /></a></div><div class="separator" style="clear: both; text-align: center;"><br />
</div><div class="separator" style="clear: both; text-align: left;">It is tempting to want a complete and robust way to describe drugs. Here is an outline classification of important drug properties relating to the series of new drug approvals we have been writing for some time now. We think it captures quite a lot.</div><div class="separator" style="clear: both; text-align: left;"><br />
</div><div class="separator" style="clear: both; text-align: left;">http://www.few.vu.nl/~frankh/postscript/WWW-WS04.pdf</div><div class="separator" style="clear: both; text-align: left;"><br />
</div><div class="separator" style="clear: both; text-align: left;">http://www.elsevier.com/wps/find/bibliographicdatabasedescription.cws_home/707574/description#description</div><div class="separator" style="clear: both; text-align: left;"><br />
</div><div class="separator" style="clear: both; text-align: left;">Both of these are proprietary.</div><div class="separator" style="clear: both; text-align: left;"><br />
</div><div class="separator" style="clear: both; text-align: left;"><br />
</div><b><u>Drug Substance Ontology</u></b><br />
<br />
<u>Drug Therapeutic Class</u><br />
<br />
<ul><li>Supplement</li>
<li>Therapeutic</li>
<li>&nbsp;&nbsp;Radiotherapeutic</li>
<li>Imaging Agent</li>
<li>&nbsp;&nbsp;Radiolabelled</li>
<li>Diagnostic Agent</li>
</ul><br />
<br />
<u>Drug Substance Type</u><br />
<br />
<ul><li>Biological</li>
<li>&nbsp;&nbsp;Gene Therapy</li>
<li>&nbsp;&nbsp;Cell Therapy</li>
<li>&nbsp;&nbsp;Oligosaccharide</li>
<li>&nbsp;&nbsp;Oligopeptide</li>
<li>&nbsp;&nbsp; &nbsp; Peptide</li>
<li>&nbsp;&nbsp; &nbsp; Protein</li>
<li>&nbsp;&nbsp; &nbsp; mAb</li>
<li>&nbsp;&nbsp; &nbsp; Enzyme</li>
<li>&nbsp;&nbsp;Oligonucleotide</li>
<li>&nbsp;&nbsp; &nbsp; RNA</li>
<li>&nbsp;&nbsp; &nbsp; DNA</li>
<li>&nbsp;&nbsp; &nbsp; PNA</li>
<li>Organic Small Molecule</li>
<li>&nbsp;&nbsp; Synthetic</li>
<li>&nbsp;&nbsp; Natural Product</li>
<li>Inorganic</li>
</ul><br />
<u>Drug Substance Stereochemistry</u><br />
<br />
<ul><li>Enantiomer</li>
<li>Diastereomer</li>
<li>Racemate</li>
</ul><br />
<u>Drug Formulation</u><br />
<br />
<ul><li>Salt</li>
<li>Zwitterion</li>
</ul><br />
<u>Drug Dosing and Delivery</u><br />
<br />
<ul><li>Oral</li>
<li>Parenteral</li>
<li>Topical</li>
</ul><br />
<br />
<u>Drug Active Component</u><br />
<br />
<ul><li>Prodrug</li>
</ul>